Details of the Drug

General Information of Drug (ID: DMPU168)

• Drug Name: TgDCC-E1A
• Synonyms: E1A tumor supressor gene product, Targeted Genetics; RGG-0853; DC-cholesterol (E1A); E1A/DC-cholesterol liposomes, Targeted Genetics; Gene therapy (cancer), Targeted Genetics/MD Anderson

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 2	[1]

• Cross-matching ID:
  DrugBank ID: DB18669
  TTD ID: D0IL4C

References

• [1] ClinicalTrials.gov (NCT02157870) A Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer. U.S. National Institutes of Health.